LVLydia M.M. Vermeer
Lydia M.M. Vermeer
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lydia M.M. Vermeer has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan A. Doorn
Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, 180 South Grand Avenue, Iowa City, Iowa 52242, United States
3 shared publications - Virginia R. Florang
Division of Medicinal and Natural Products Chemistry, College of Pharmacy, The University of Iowa, 115 S. Grand Ave, Iowa City, Iowa 52242, USA
2 shared publications - Colin A. Higgins
Division of Medicinal and Natural Products Chemistry, The University of Iowa College of Pharmacy, Iowa City, IA 52242, USA
1 shared publication - David L. Roman
Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa 52242, United States
1 shared publication
Latest Publications
- 1 September 2012
- Published by Elsevier in Brain Research
- Vol. 1474, 100-109
Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity
- 1 September 2012
- Published by Elsevier in Brain Research
- Vol. 1474, 100-109
Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity
- 31 May 2012
- Published by Elsevier in Protein Expression and Purification
- Vol. 84 (2) , 219-223
Expression and purification of recombinant human tyrosine hydroxylase as a fusion protein in Escherichia coli
- 31 May 2012
- Published by Elsevier in Protein Expression and Purification
- Vol. 84 (2) , 219-223
Expression and purification of recombinant human tyrosine hydroxylase as a fusion protein in Escherichia coli
- 1 August 2011
- Published by Elsevier in NeuroToxicology
- Vol. 32 (4) , 471-477
Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite
- 1 August 2011
- Published by Elsevier in NeuroToxicology
- Vol. 32 (4) , 471-477
Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite